CCR9:CCL25 in melanoma metastatic to small intestine.

scientific article published in September 2009

CCR9:CCL25 in melanoma metastatic to small intestine. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1011050604
P356DOI10.1007/S11912-009-0056-9
P698PubMed publication ID19679006

P2093author name stringKim A Margolin
P2860cites workChemokines as mediators of neovascularizationQ30438032
Melanoma in the gastrointestinal tractQ33801001
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicryQ33874221
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factorsQ35954365
Targeting STAT3 affects melanoma on multiple frontsQ36178382
The good and the bad of chemokines/chemokine receptors in melanomaQ37394981
Functional CCR9 expression is associated with small intestinal metastasisQ40566438
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2Q78701428
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cellsQ78710357
P433issue5
P304page(s)331-332
P577publication date2009-09-01
P1433published inCurrent Oncology ReportsQ2264969
P1476titleCCR9:CCL25 in melanoma metastatic to small intestine.
P478volume11

Search more.